Niva Bupa Health Insurance Company Ltd Stock Price Today (NSE: NIVABUPA)
Fundamental Score
Niva Bupa Health Insurance Company Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Niva Bupa Health Insurance Company Ltd share price today is ₹84.03, down 0.56% on NSE/BSE as of 18 June 2026. Niva Bupa Health Insurance Company Ltd (NIVABUPA) is a Mid-cap company in the General Insurance sector with a market capitalisation of ₹13.66K (Cr). The 52-week high for NIVABUPA share price is ₹92.90 and the 52-week low is ₹67.50. At a P/E ratio of 147.45x, NIVABUPA is currently trading above its industry average P/E of 44.24x. The company has a Return on Equity (ROE) of 8.18% and a debt-to-equity ratio of 0.07.
Niva Bupa Health Insurance Company Ltd Share Price Chart — NSE/BSE Historical Performance
Niva Bupa Health Insurance Company Ltd share price chart: 8.47% return over the past month. 52-week high ₹92.90, 52-week low ₹67.50.
Niva Bupa Health Insurance Company Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹84.50 | ₹84.87 | ₹82.24 | ₹84.03 | 21.98L (Cr) | |
| ₹84.80 | ₹85.23 | ₹83.57 | ₹84.50 | 8.91L (Cr) | |
| ₹82.96 | ₹85.25 | ₹82.90 | ₹83.50 | 14.63L (Cr) | |
| ₹83.61 | ₹83.61 | ₹83.61 | ₹83.61 | 0.00 (Cr) | |
| ₹84.08 | ₹84.49 | ₹83.15 | ₹83.61 | 7.61L (Cr) | |
| ₹84.10 | ₹85.00 | ₹83.81 | ₹84.08 | 5.69L (Cr) | |
| ₹86.00 | ₹86.27 | ₹83.48 | ₹83.96 | 15.58L (Cr) | |
| ₹83.98 | ₹86.46 | ₹83.71 | ₹85.99 | 58.79L (Cr) | |
| ₹82.00 | ₹85.50 | ₹80.89 | ₹83.62 | 39.56L (Cr) | |
| ₹80.76 | ₹82.52 | ₹80.00 | ₹81.51 | 9.25L (Cr) |
Niva Bupa Health Insurance Company Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹84.80 | ₹85.23 | ₹82.24 | ₹84.03 | -0.91% | |
| ₹81.00 | ₹89.77 | ₹77.68 | ₹83.50 | +3.09% | |
| ₹73.20 | ₹81.81 | ₹70.00 | ₹78.32 | +6.99% | |
| ₹70.10 | ₹77.00 | ₹67.50 | ₹70.21 | +0.16% | |
| ₹77.40 | ₹80.51 | ₹74.69 | ₹75.09 | -2.98% | |
| ₹75.57 | ₹80.50 | ₹73.44 | ₹78.87 | +4.37% | |
| ₹73.97 | ₹78.10 | ₹73.10 | ₹75.40 | +1.93% | |
| ₹75.29 | ₹78.69 | ₹72.00 | ₹74.34 | -1.26% | |
| ₹81.65 | ₹83.70 | ₹73.50 | ₹75.06 | -8.07% | |
| ₹81.52 | ₹91.20 | ₹79.83 | ₹81.84 | +0.39% | |
| ₹84.70 | ₹89.91 | ₹78.80 | ₹81.52 | -3.75% | |
| ₹82.15 | ₹92.90 | ₹80.51 | ₹87.55 | +6.57% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Niva Bupa Health Insurance Company Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Niva Bupa Health Insurance Company Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NIVABUPA across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Revenue Growth (19.13%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (38.42% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (40.07% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.07)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹3485.58 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (55.41%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Strong Institutional Confidence (FII+DII: 26.03%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (8.18%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (7.45%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-5.36%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 147.45x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-370.89%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Niva Bupa Health Insurance Company Ltd vs General Insurance Peers
Peer Comparison - General Insurance
Compare Niva Bupa Health Insurance Company Ltd with 5 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Niva Bupa Health Insurance Company LtdNiva Bupa Healt...Selected✓ NIVABUPA • 544286 | 48.6/100 | ₹84.03₹84 | ₹13655.62₹13655.62 | 147.45Average 147.4 Average | 8.18%Poor 8.18% Poor | 7.45%Poor 7.45% Poor | 0.07Excellent 0.1 Excellent | 40.07%Excellent 40.07% Excellent | 38.42%Excellent 38.42% Excellent | 0.00% |
61.1/100 | ₹1822.80₹1823 | ₹99138.73₹99138.73 | 35.40Average 35.4 Average | 18.80%Good 18.80% Good | 24.86%Excellent 24.86% Excellent | 0.00Excellent 0.0 Excellent | 16.00%Excellent 16.00% Excellent | 15.78%Excellent 15.78% Excellent | 0.63% | |
General Insurance Corporation of IndiaGeneral Insuran... GICRE • 540755 | 60.6/100 | ₹389.30₹389 | ₹68105.76₹68105.76 | 7.11Average 7.1 Average | 10.99%Average 10.99% Average | 13.32%Average 13.32% Average | 0.00Excellent 0.0 Excellent | 105.29%Excellent 105.29% Excellent | -0.29%Poor -0.29% Poor | 2.58% |
Go Digit General Insurance LtdGo Digit Genera... GODIGIT • 544179 | 39.4/100 | ₹307.65₹308 | ₹32842.69₹32842.69 | 64.64Average 64.6 Average | 11.87%Average 11.87% Average | 10.80%Average 10.80% Average | 0.08Excellent 0.1 Excellent | — — | — — | 0.00% |
Star Health and Allied Insurance Company LimitedStar Health and... STARHEALTH • 543412 | 48.8/100 | ₹507.35₹507 | ₹28287.46₹28287.46 | 53.07Average 53.1 Average | 9.37%Poor 9.37% Poor | 11.98%Average 11.98% Average | 0.06Excellent 0.1 Excellent | 18.65%Excellent 18.65% Excellent | 26.42%Excellent 26.42% Excellent | 0.00% |
The New India Assurance Co LtdThe New India A... NIACL • 540769 | 35.3/100 | ₹164.57₹165 | ₹27900.73₹27900.73 | 24.01Average 24.0 Average | 3.64%Poor 3.64% Poor | 3.59%Poor 3.59% Poor | 0.00Excellent 0.0 Excellent | -6.32%Poor -6.32% Poor | 8.87%Good 8.87% Good | 1.06% |
Top General Insurance Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- ICICI Lombard General Insurance Company Limited share price99138.73 Cr
- General Insurance Corporation of India share price68105.76 Cr
- Go Digit General Insurance Ltd share price32842.69 Cr
- Star Health and Allied Insurance Company Limited share price28287.46 Cr
- The New India Assurance Co Ltd share price27900.73 Cr
Niva Bupa Health Insurance Company Ltd PE Ratio History
Historical price-to-earnings ratio for NIVABUPA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹1.20 | ₹75.40 | 62.8x |
| FY 2024 | ₹0.45 | ₹84.11 | 187.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Niva Bupa Health Insurance Company Ltd Quarterly Performance
Latest quarterly metrics for NIVABUPA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
19.13%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-370.89%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
38.42%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
40.07%
Compounded annual net profit growth over 5 years
Niva Bupa Health Insurance Company Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NIVABUPA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Niva Bupa Health Insurance Company Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Niva Bupa Health Insurance Company Ltd (NIVABUPA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Niva Bupa Health Insurance Company Ltd
About NIVABUPA (Niva Bupa Health Insurance Company Ltd)
Niva Bupa Health Insurance Company Ltd is a prominent health insurance provider in India, focused on delivering comprehensive and innovative healthcare solutions to a diverse range... of customers. With a commitment to customer-centricity, Niva Bupa offers a wide array of health insurance plans meticulously designed to cater to the unique healthcare needs of individuals, families, and organizations. Their dedication extends beyond merely offering policies; they strive to be partners in their customers' healthcare journeys, ensuring access to quality medical care and peace of mind. Niva Bupa constantly seeks to redefine the health insurance landscape through technological advancements and personalized service. The company's robust portfolio encompasses plans tailored for various demographics, including individual and family health insurance options, specialized plans for Non-Resident Indians (NRIs) and senior citizens, and policies designed to cover personal accidents and critical illnesses. Recognizing the increasing need for global coverage, Niva Bupa also offers comprehensive travel insurance solutions, including options specifically designed for international travel and students studying abroad. These plans provide coverage for medical emergencies, trip cancellations, and other unforeseen circumstances, ensuring travelers can explore the world with confidence. Beyond individual and family needs, Niva Bupa provides tailored corporate insurance solutions, including group health insurance, group personal accident coverage, and Outpatient Department (OPD) coverage. They understand the unique needs of businesses, offering customized plans for start-ups and larger organizations. Niva Bupa aims to simplify the claims process, ensuring efficient and hassle-free experiences for its corporate clients. This commitment to seamless service delivery makes Niva Bupa a trusted partner for organizations seeking to protect the health and well-being of their employees.
Company Details
Key Leadership
Latest News
NIVABUPA Share Price: Frequently Asked Questions
What is the current share price of Niva Bupa Health Insurance Company Ltd?
Niva Bupa Health Insurance Company Ltd (NIVABUPA) trades at ₹84.03 on NSE and BSE. Market cap ₹13.66K (Cr). Educational data only.
What is the P/E ratio of Niva Bupa Health Insurance Company Ltd?
Niva Bupa Health Insurance Company Ltd has a P/E of 147.45x vs industry average 44.24x.
What is the Bull Run score for Niva Bupa Health Insurance Company Ltd?
Niva Bupa Health Insurance Company Ltd has a Bull Run score of 48.6/100 based on 25+ financial parameters.
Does Niva Bupa Health Insurance Company Ltd pay dividends?
Niva Bupa Health Insurance Company Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Niva Bupa Health Insurance Company Ltd?
Niva Bupa Health Insurance Company Ltd has ROE of 8.18%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Niva Bupa Health Insurance Company Ltd?
Niva Bupa Health Insurance Company Ltd has debt-to-equity of 0.07.
Is Niva Bupa Health Insurance Company Ltd a good investment?
Bull Run gives Niva Bupa Health Insurance Company Ltd a score of 48.6/100. This is not investment advice — consult a SEBI-registered advisor.